Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Clinical-stage biotechnology company Amgen has signed an agreement to acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of around $1.9bn.
Gastric Cancer
-
05 Mar 2021
-
19 Jan 2021
Etana to launch Innovent Biologics’ cancer drug BYVASDA in Indonesia
Chinese pharmaceutical company Innovent Biologics has signed an out-license agreement with Etana Biotechnologies to develop and commercialise cancer drug BYVASDA (Bevacizumab Biosimilar) in Indonesia.